Combined application of PD‐1/PD‐L1 antibody and TIM‐3 antibody can better inhibit tumor growth, suggesting that the upregulation of Tim‐3 expression may be involved in the acquired resistance of PD‐1 blocker.17 This evidence concerns the gene HAVCR2 and neoplasm.